AG
Therapeutic Areas
Recordati Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Rare Disease Portfolio | Cushing's Disease, Acromegaly, Acute Hepatic Porphyrias | Marketed |
| Specialty & Primary Care Portfolio | Cardiovascular, Urology, Mental Health | Marketed |
Leadership Team at Recordati
RK
Robert Koremans
Chief Executive Officer
MM
Mike McClellan
Chief Financial Officer
AM
Alberto Martinez
Executive VP Specialty & Primary Care Business Unit
SP
Scott Pescatore
Executive VP Rare Diseases Business Unit
BB
Bibianne Bon
Group Chief Legal Officer
AA
Alessandra Abate
Group Chief People and Culture Officer
GF
Gabriele Finzi
Executive VP Corporate Development, Licensing & Innovation
MZ
Milan Zdravkovic
Executive VP Research & Development and Chief Medical Officer